Inactive Instrument

All News Apexigen, Inc.

Equities

APGN

US03759B1026

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Apexigen, Inc.(NasdaqCM:APGN) dropped from S&P TMI Index	23-08-25	CI
Pyxis Oncology Completes Acquisition of Apexigen	23-08-23	MT
Apexigen, Inc.(NasdaqCM:APGN) dropped from NASDAQ Composite Index	23-08-23	CI
Pyxis Oncology, Inc. completed the acquisition of Apexigen, Inc. from entities associated with Pfizer Inc., Lincoln Park Capital, LLC, managed by Laurion Capital Management LP, Bayer World Investments B.V. and others.	23-08-22	CI
Apexigen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
APEXIGEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN	23-08-10	BU
Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting	23-06-03	AQ
Apexigen, Inc. Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology 2023 Annual Meeting	23-06-03	CI
APEXIGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN	23-05-30	BU
North American Morning Briefing : Nvidia Surge -2-	23-05-25	DJ
Shareholder Alert: Ademi LLP investigates whether Apexigen, Inc. has obtained a Fair Price in its transaction with Pyxis Oncology	23-05-24	PR
Wall Street Set to Open Lower as Investors Await Progress on Debt-Ceiling Talks Ahead of Fed Minutes Release	23-05-24	MT
Sector Update: Health Care Stocks Mixed Premarket Wednesday	23-05-24	MT
Sector Update: Health Care	23-05-24	MT
Transcript : Apexigen, Inc., Pyxis Oncology, Inc. - M&A Call	23-05-24
APGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apexigen, Inc. Is Fair to Shareholders	23-05-24	BU
US Futures Lower as Investors Eye Debt Ceiling Talks, Await Fed Minutes Release	23-05-24	MT
Top Premarket Gainers	23-05-24	MT
Pyxis Oncology to Acquire Apexigen in $16 Million All-Stock Deal	23-05-24	MT
Pyxis Oncology to Acquire Apexigen	23-05-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Apexigen, Inc.

Equities

APGN

US03759B1026

All News

Filters